Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 368-371

  Donat, S Machele ^a   Herr, Harry W ^b   Bajorin, Dean F ^b   Fair, William R ^b   Sogani, Pramod C ^b   Russo, Paul ^b   Sheinfeld, Joel ^b   Scher, Howard I ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

Bladder; Bladder neoplasms; Cystectomy; Drug therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; M VAC PROTOCOL; M-VAC PROTOCOL; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; CYSTECTOMY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; CYSTECTOMY; DOXORUBICIN; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0030213488     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65852-X     Document Type: Article

References (12)

1. Vieweg, J., Whitmore, W. F., Jr., Herr, H. W., Sogani, P. C., Russo, P., Sheinfeld, J. and Fair, W. R.: The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer, 73: 3020, 1994.
2. Gospodarowicz, M. K., Hawkins, N. V., Rawlings, G. A., Connolly, J. G., Jewett, M. A. S., Thomas, G. M., Herman, J. G., Garrett, P. G., Chua, T., Duncan, W., Buckspan, M., Sugar, L. and Rider, W. D.: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J. Urol., 142: 1448, 1989.
3. Kaufman, D. S., Shipley, W. U., Griffin, P. P., Heney, N. M., Althausen, A. F. and Efird, J. T.: Selective bladder preservation by combination treatment of invasive bladder cancer. New Engl. J. Med., 329: 1377, 1993.
4. Scher, H. I., Yagoda, A., Herr, H. W., Sternberg, C. N., Bosl, G., Morse, M. J., Sogani, P. C., Watson, R. C., Dershaw, D. D., Reuter, V., Geller, N., Hollander, P. S., Vaughan, E. D., Jr., Whitmore, W. F., Jr. and Fair, W. R.: Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J. Urol., 139: 470, 1988.
5. Geller, N. L., Sternberg, C. N., Pennenberg, D., Scher, H. and Yagoda, A.: Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy. Cancer, 67: 1525, 1991.
6. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D., Jr., Bander, N., Weiselberg, L. R., Geller, N., Hollander, P. S., Lipperman, R., Fair, W. R. and Whitmore, W. F., Jr.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139: 461, 1988.
7. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Geller, N., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D. and Bander, N.: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer, 64: 2448, 1989.
8. Schultz, P. K., Herr, H. W., Zhang, Z. F., Bajorin, D. F., Seidman, A., Sarkis, A., Fair, W. R., Scher, D., Bosl, G. J. and Scher, H. I.: Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J. Clin. Oncol., 12: 1394, 1994.
9. Scher, H., Herr, H., Sternberg, C., Fair, W., Bosl, G., Morse, M., Sogani, P., Watson, R., Dershaw, D. and Reuter, V.: Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. Brit. J. Urol., 64: 250, 1989.
10. Gospodarowicz, M. K., Rider, W. D., Keen, C. W., Connolly, J. G., Jewett, M. A., Cummings, B. J., Duncan, W., Warde, P. and Chua, T.: Bladder cancer: long-term follow-up results of patients treated with radical radiation. Clin. Oncol., 3: 155, 1991.
11. Montie, J. E., Whitmore, W. F., Grabstald, H. M. and Yagoda, A.: Unresectable carcinoma of the bladder. Cancer, 51: 2351, 1983.
12. Levine, E. G. and Raghavan, D.: MVAC for bladder cancer: time to move forward again. J. Clin. Oncol., 11: 387, 1993.